SF — STIFEL FINANCIAL CORP
—
NYSE ·
Financials ·
Capital Markets ·
CIK 720672 ·
Last close
$70.35
Market Cap
$10.62B
52W High
$88.61
52W Low
$67.52
ADV30
1,206,723
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 1,463,120,000 | — | — | 251,419,000 | 42,893,152,000 | 3,262,647,000 | 36,908,670,000 |
| Dec 2025 | 1,544,162,000 | — | — | 264,361,000 | 41,270,782,000 | 2,569,350,000 | 35,293,465,000 |
| Sep 2025 | 1,413,589,000 | — | — | 211,371,000 | 41,687,360,000 | 3,614,937,000 | 35,931,225,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$985,664,000
Investing CF
$-1,697,586,000
Financing CF
$882,296,000
CapEx
$-93,362,000
Dividends Paid
$-250,864,000
Buybacks
$-248,226,000
EPS Diluted TTM
$5.59
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$4,269,894,000
Inventory
—
Receivables
$1,798,232,000
ST Investments
$97,018,000
EBIT TTM
—
Pretax Income TTM
$1,133,847,000
Interest Exp TTM
$791,737,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,834,527,232
EBITDA
—
Free Cash Flow
—
Enterprise Value
$10,631,013,376
Total Cash
$5,224,914,944
Total Debt
$3,127,030,016
Shares Out
151,001,734
Trailing EPS
$5.59
Book Value
$35.15
ROE
16.4%
ROA
2.2%
Div Yield
1.71%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,463,554,000 | — | 683,779,000 | 41,270,782,000 | 35,293,465,000 | 5,977,317,000 | 1,117,029,000 |
| Dec 2024 | 4,907,497,000 | — | 731,379,000 | 39,895,540,000 | 34,208,770,000 | 5,686,770,000 | 490,437,000 |
| Dec 2023 | 4,290,600,000 | — | 522,536,000 | 37,727,460,000 | 32,433,029,000 | 5,294,431,000 | 499,328,000 |
| Dec 2022 | 4,333,687,000 | — | 662,155,000 | 37,196,124,000 | 31,867,653,000 | 5,328,471,000 | 1,157,415,000 |
TTM Snapshot
Revenues TTM
$945,458,000
NetIncome TTM
$-46,217,000
OpCashFlow TTM
$0
Assets (Latest)
$4,951,900,000
Forward EPS
$7.33
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $75.00 · spot: $70.35 · call volume: 1,143 · put volume: 60
Expected Move to 2026-11-20:
±$7.95
(11.30%) —
implied range
$62.40 –
$78.30
· ATM straddle on $70.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FUTU | Futu Holdings Ltd | $10.71B | $111.87 | — |
| FRHC | Freedom Holding Corp. | $10.98B | $172.08 | — |
| EVR | Evercore Inc. | $10.11B | $262.91 | — |
| TW | Tradeweb Markets Inc. | $11.54B | $101.19 | — |
| AMG | AFFILIATED MANAGERS GROUP, INC. | $9.66B | $373.69 | — |
News headlines (Yahoo Finance, 1h cache)
This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
2026-09-25 13:26 · Yahoo
Stifel Reports August 2026 Operating Data
2026-09-24 20:25 · Yahoo
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
2026-09-24 20:05 · Yahoo
Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
2026-09-23 13:00 · Yahoo
Altimmune to Participate in Stifel Cardiometabolic Forum
2026-09-23 12:00 · Yahoo
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
2026-09-23 11:00 · Yahoo
NKE Stock In Focus After Stifel Lowers Price Target To $40 – A Look At Some Key Highlights
2026-09-21 14:18 · Yahoo
Stifel Financial (SF) Expands Venture Banking, Is The Upside Already Priced In?
2026-09-19 06:11 · Yahoo
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
2026-09-17 20:30 · Yahoo
Stifel Expands Venture Banking Presence Across East Coast With Senior Hires
2026-09-17 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.